These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38185349)

  • 1. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Voisin T; Joannes A; Morzadec C; Lagadic-Gossmann D; Naoures CL; De Latour BR; Rouze S; Jouneau S; Vernhet L
    J Nutr Biochem; 2024 Mar; 125():109558. PubMed ID: 38185349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Joannes A; Morzadec C; Duclos M; Gutierrez FL; Chiforeanu DC; Le Naoures C; De Latour B; Rouzé S; Wollin L; Jouneau S; Vernhet L
    Toxicol Appl Pharmacol; 2022 Apr; 441():115972. PubMed ID: 35276128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
    Joannes A; Voisin T; Morzadec C; Letellier A; Gutierrez FL; Chiforeanu DC; Le Naoures C; Guillot S; De Latour BR; Rouze S; Jaillet M; Crestani B; Wollin L; Jouneau S; Vernhet L
    Pulm Pharmacol Ther; 2023 Dec; 83():102267. PubMed ID: 37972706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling.
    Epstein Shochet G; Brook E; Bardenstein-Wald B; Shitrit D
    Respir Res; 2020 Feb; 21(1):56. PubMed ID: 32070329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
    Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
    Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.
    Huang Y; Xie Y; Abel PW; Wei P; Plowman J; Toews ML; Strah H; Siddique A; Bailey KL; Tu Y
    Biochem Pharmacol; 2020 Oct; 180():114172. PubMed ID: 32712053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
    Herrmann FE; Wollin L; Wirth J; Gantner F; Lämmle B; Wex E
    Br J Pharmacol; 2017 Nov; 174(21):3848-3864. PubMed ID: 28810065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation.
    Guo X; Adeyanju O; Olajuyin AM; Mandlem V; Sunil C; Adewumi J; Huang S; Tucker TA; Idell S; Qian G
    Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1190-C1200. PubMed ID: 37661917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
    Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
    Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
    Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
    J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β
    Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IPF lung fibroblasts have a senescent phenotype.
    Álvarez D; Cárdenes N; Sellarés J; Bueno M; Corey C; Hanumanthu VS; Peng Y; D'Cunha H; Sembrat J; Nouraie M; Shanker S; Caufield C; Shiva S; Armanios M; Mora AL; Rojas M
    Am J Physiol Lung Cell Mol Physiol; 2017 Dec; 313(6):L1164-L1173. PubMed ID: 28860144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation.
    Reed EB; Orbeta S; Miao BA; Sitikov A; Chen B; Levitan I; Solway J; Mutlu GM; Fang Y; Mongin AA; Dulin NO
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L111-L123. PubMed ID: 38084409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
    Tang F; Gong H; Ke T; Yang W; Yang Y; Liu Z
    Discov Med; 2024 Aug; 36(187):1616-1626. PubMed ID: 39190377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
    Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
    PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
    Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
    J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.